Renal Sympathetic Denervation and Systemic Hypertension

American Journal of Cardiology

Volumn 105, Issue 4, 2010, Pages 570-576

  Doumas, Michael ^a   Faselis, Charles ^a   Papademetriou, Vasilios ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; CARDIOMEGALY; HEART ATRIUM FIBRILLATION; HISTORY; HUMAN; INTERVENTION STUDY; KIDNEY DENERVATION; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; REVIEW; SYMPATHECTOMY;

CATHETER ABLATION; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; KIDNEY; LIFE EXPECTANCY; SYMPATHECTOMY; TREATMENT OUTCOME;

EID: 75349085866     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.10.027     Document Type: Review

References (75)

1. Calhoun D.A., Jones D., Textor S., Goff D.C., Murphy T.P., Toto R.D., White A., Cushman W.C., White W., Sica D., Ferdinand K., Giles T.D., Falkner B., and Carey R.M. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51 (2008) 1403-1419
2. Sarafidis P.A., and Bakris G.L. Resistant hypertension. An overview of evaluation and treatment. J Am Coll Cardiol 52 (2008) 1749-1757
3. Moser M., and Setaro J.F. Resistant or difficult-to-control hypertension. N Engl J Med 355 (2006) 385-392
4. Wojciechowski D., Papademetriou V., Faselis C., and Fletcher R. Evaluation and treatment of resistant or difficult-to-control hypertension. J Clin Hypertens 10 (2008) 837-843
5. Page I.H., and Heuer G.J. A surgical treatment of essential hypertension. J Clin Invest 14 (1935) 22-26
6. Freyberg R.H., and Peet M.M. The effect on the kidney of bilateral splanchnicectomy in patients with hypertension. J Clin Invest 16 (1937) 49-65
7. Smithwick R.H. Surgical treatment of hypertension. Am J Med 4 (1948) 744-759
8. Isberg E.M., and Peet M.M. The influence of supradiaphragmatic splanchnicectomy on the heart in hypertension. Am Heart J 35 (1948) 567-583
9. Allen E.V. Sympathectomy for essential hypertension. Circulation 6 (1952) 131-140
10. Whitelaw G.P., Kinsey D., and Smithwick R.H. Factors influencing the choice of treatment in essential hypertension: surgical, medical, or a combination of both. Am J Surg 107 (1964) 220-231
11. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 202 (1967) 1028-1034
12. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 90 through 114 mmHg. JAMA 213 (1970) 1143-1152
13. Illig K., Levy M., Sanchez L., Trachiotis G.D., Shanley C., Irwin E., Pertile T., Kieval R., and Cody R. An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial. J Vasc Surg 44 (2006) 1213-1218
14. Tordoir J.H.M., Scheffers I., Schmidli J., Savolainen H., Liebeskind U., Hansky B., Herold U., Irwin E., Kroon A.A., de Leeuw P., Peters T.K., Kieval R., and Cody R. An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multicenter feasibility trial for the treatment of resistant hypertension. Eur J Endovasc Surg 33 (2007) 414-421
15. Krum H., Schlaich M., Whitburn R., Sobotka P.A., Sadowski J., Bartus K., Kapelak B., Walton A., Sievert H., Thambar S., Abraham W.T., and Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373 (2009) 1275-1281
16. DiBona G.F., and Kopp U.C. Neural control of renal function. Physiol Rev 77 (1997) 75-197
17. Kopp U.C., and DiBona G.F. The neural control of renal function. In: Seldin G., and Giebisch G. (Eds). The Kidney: Physiology and Pathophysiology. 3rd ed. (2006), Raven, New York 981-1006
18. Barajas L., Liu L., and Powers K. Anatomy of the renal innervation: intrarenal aspects and ganglia of origin. Can J Physiol Pharmacol 70 (1992) 735-749
19. Luff S.E., Hengstberger S.G., McLahlan E.M., and Anderson W.P. Distribution of sympathetic neuroeffector junctions in the juxtaglomerular region of the rabbit kidney. J Auton Nerv Syst 40 (1992) 239-253
20. Barajas L., Powers K., and Wang P. Innervation of the renal cortical tubules: a quantitative study. Am J Physiol 247 (1984) F50-F60
21. Esler M. The sympathetic system and hypertension. Am J Hypertens 13 (2000) S99-S105
22. Esler M., Rumantir M., Kaye D., Jennings G., Hastings J., Socratous F., and Lambert G. Sympathetic nerve biology in essential hypertension. Clin Exp Pharmacol Physiol 28 (2001) 986-989
23. Wurzner G., Chiolero A., Maillard M., Nussberger J., Hayoz D., Brunner H.R., and Burnier M. Renal and neurohormonal responses to increasing levels of lower body negative pressure in men. Kidney Int 60 (2001) 1469-1476
24. Jackson E.K. Autonomic control of the kidney. In: Robertson D., Biaggioni I., Burnstock G., and Low P. (Eds). Primer on the Autonomic Nervous System. 2nd ed. (2004), Elsevier, New York 157-161
25. Kopp U., Aurell M., Nilsson I.M., and Ablad B. The role of beta-1-adrenoceptors in the renin release response to graded renal sympathetic nerve stimulation. Pflugers Arch 387 (1980) 107-113
26. Osborn J.L., DiBona G.F., and Thames M.D. Beta-1 receptor mediation of renin secretion elicited by low-frequency renal nerve stimulation. J Pharmacol Exp Ther 216 (1981) 265-269
27. Johns E.J. Role of angiotensin II and the sympathetic nervous system in the control of renal function. J Hypertens 7 (1989) 695-701
28. Bello-Reuss E., Colindres R.E., Pastoriza-Munoz E., Mueller R.A., and Gottschalk C.W. Effects of acute unilateral renal denervation in the rat. J Clin Invest 56 (1975) 208-217
29. Bello-Reuss E., Pastoriza-Munoz E., and Colindres R.E. Acute unilateral renal denervation in rats with extracellular volume expansion. Am J Physiol 232 (1977) F26-F32
30. La Grange R.G., Sloop C.H., and Schmid H.E. Selective stimulation of renal nerves in the anesthetized dog. Effect on renin release during controlled changes in renal hemodynamics. Circ Res 33 (1973) 704-712
31. Hesse I.F., and Johns E.J. The effect of graded renal nerve stimulation on renal function in the anaesthetized rabbit. Comp Biochem Physiol A Comp Physiol 79 (1984) 409-414
32. Johns E.J., and Manitius J. An investigation into the neural regulation of calcium excretion by the rat kidney. J Physiol 383 (1987) 745-755
33. 2O transport in Henle's loop of the rat. Am J Physiol 243 (1982) F576-F580
34. Bonjour J.P., Churchill P.C., and Malvin R.L. Change of tubular reabsorption of sodium and water after renal denervation in the dog. J Physiol 204 (1969) 571-582
35. Szenasi G., Bencsath P., and Takacs L. Proximal tubular transport and urinary excretion of sodium after renal denervation in sodium depleted rats. Pflugers Arch 403 (1985) 146-150
36. Wu X.C., and Johns E.J. Interactions between nitric oxide and superoxide on the neural regulation of proximal fluid reabsorption in hypertensive rats. Exp Physiol 89 (2004) 255-261
37. Wu X.C., and Johns E.J. Nitric oxide modulation of neurally induced proximal tubular fluid reabsorption in the rat. Hypertension 39 (2002) 790-793
38. Yoshimoto M., Sakagami T., Nagura S., and Miki K. Relationship between renal sympathetic nerve activity and renal blood flow during natural behavior in rats. Am J Physiol Regul Integr Comp Physiol 286 (2004) R881-R887
39. Malpas S.C., and Evans R.G. Do different levels and patterns of sympathetic activation all provoke renal vasoconstriction?. J Auton Nerv Syst 69 (1998) 72-82
40. Hollenberg N.K., Williams G.H., and Adams G.F. Essential hypertension: abnormal renal vascular and endocrine responses to a mild psychological stimulus. Hypertension 3 (1981) 11-17
41. Brod J. Renal circulation. In: Brod J. (Ed). The Kidney (1973), Butterworths, London 41-75
42. Handa R.K., and Johns E.J. Interaction of the renin-angiotensin system and the renal nerves in the regulation of rat kidney function. J Physiol 369 (1985) 311-321
43. Johns E.J., Lewis B.A., and Singer B. The sodium-retaining effect of renal nerve activity in the cat: role of angiotensin formation. Clin Sci Mol Med 51 (1976) 93-102
44. Widmann C., Gibson S., Jarpe M.B., and Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79 (1999) 143-180
45. Wu W., Scholey J.W., Sonnenberg H., and Melo L.G. Renal vascular morphology and haemodynamics in Dahl salt-sensitive rats on high salt-low potassium diet: neural and genetic influences. J Hypertens 18 (2000) 783-793
46. Kopp U.C., Cicha M.Z., Nakamura K., Nusing R.M., Smith L.A., and Hokfelt T. Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves. Am J Physiol Renal Physiol 287 (2004) F1269-F1282
47. Kopp U.C., Cicha M.Z., Smith L.A., and Hokfelt T. Nitric oxide modulates renal sensory nerve fibers by mechanisms related to substance P receptor activation. Am J Physiol Regul Integr Comp Physiol 281 (2001) R279-R290
48. Liu L., and Barajas L. The rat renal nerves during development. Anat Embryol (Berl) 188 (1993) 345-361
49. Stella A., and Zanchetti A. Functional role of renal afferents. Physiol Rev 71 (1991) 659-682
50. Calaresu F.R., and Ciriello J. Renal afferent nerves affect discharge rate of medullary and hypothalamic single units in the cat. J Auton Nern Syst 3 (1981) 311-320
51. Ciriello J. Afferent renal inputs to paraventricular nucleus vasopressin and oxytocin neurosecretory neurons. Am J Physiol 275 (1998) R1745-R1754
52. Caverson M.M., and Ciriello J. Effect of stimulation of afferent renal nerves on plasma levels of vasopressin. Am J Physiol 252 (1987) R801-R807
53. Coote J.H. A role for the paraventricular nucleus of the hypothalamus in the autonomic control of heart and kidney. Exp Physiol 90 (2004) 169-173
54. Ferguson A.V., Latchford K.J., and Samson W.K. The paraventricular nucleus of the hypothalamus-a potential target for integrative treatment of autonomic dysfunction. Expert Opin Ther Targets 12 (2008) 717-727
55. Zhong M.K., Duan Y.C., Chen A.D., Xu B., Gao X.Y., De W., and Zhu G.Q. Paraventricular nucleus is involved in the central pathway of cardiac sympathetic afferent reflex in rats. Exp Physiol 93 (2008) 746-753
56. Bigazzi R., Kogosov E., and Campese V.M. Altered norepinephrine turnover in the brain of rats with chronic renal failure. J Am Soc Nephrol 4 (1994) 1901-1907
57. Ye S., Ozgur B., and Campese V.M. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 51 (1997) 722-727
58. Pan J.Y., Bishop V.S., Ball N.A., and Haywood J.R. Inability of dorsal spinal rhizotomy to prevent renal wrap hypertension in rats. Hypertension 7 (1985) 722-728
59. Janssen B.J.A., Van Essen H., Vervoort-Peters L.H.T.M., Struyker-Boudier H.A.J., and Smith J.F.M. Role of afferent renal nerves in spontaneous hypertension in rats. Hypertension 13 (1989) 327-333
60. Kopp U.C., Cicha M.Z., and Smith L.A. Dietary sodium loading increases arterial pressure in afferent renal-denervated rats. Hypertension 42 (2003) 968-973
61. Wang D.H., Li J., and Qiu J. Salt-sensitive hypertension induced by sensory denervation: introduction of a new model. Hypertension 32 (1998) 649-653
62. Keith N.M., Wagener H.P., and Barker N.W. Some different types of essential hypertension: their course and prognosis. Am J Med Sc 197 (1939) 332-353
63. Smithwick R.H. Hypertensive vascular disease: results of and indications for splanchnicectomy. J Chron Dis 1 (1955) 477-496
64. Cappato R., Calkins H., Chen S.A., Davies W., Iesaka Y., and Kalman J. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol 53 (2009) 1798-1803
65. Belhassen B. A 1 per 1,000 mortality rate after catheter ablation of atrial fibrillation. An acceptable risk?. J Am Coll Cardiol 53 (2009) 1804-1806
66. Esler M., Schlaich M., Sobotka P., Whitbourn R., Sadowski J., Bartus K., Kapelak B., Walton A., Sievert H., Thambar S., Abraham W., and Krum H. Catheter-based renal denervation reduces total body and renal noradrenaline spillover and blood pressure in resistant hypertension. J Hypertens 27 (2009) S167
67. White P.D., Smithwick R.H., Matthews M.W., and Evans E. The electrocardiogram in hypertension. The effect of radical lumbodorsal sympathectomy. Am Heart J 30 (1945) 165-183
68. Chavez I., and Mendez L. Surgical treatment of hypertensive heart disease and of heart failure of hypertension. Am Heart J 37 (1949) 523-530
69. Peet M.M. Hypertension and its surgical treatment by bilateral supradiaphragmatic splanchnicectomy. Am J Surg 75 (1948) 48-68
70. DiBona G.F. Neural control of renal function: cardiovascular implications. Hypertension 13 (1989) 539-548
71. Bright R. Reports of Medical Cases Selected With a View of Illustrating the Symptoms and Cure of Diseases by a Reference to Morbid Anatomy (1827), Longman, Rees, Orme, Brown, Green, London 724-766
72. Converse Jr. R.L., Jacobsen T.N., Toto R.D., Jost C.M., Cosentino F., Fouad-Tarazi F., and Victor R.G. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327 (1992) 1912-1918
73. Hausberg M., Kosch M., Harmelink P., Barenbrock M., Hohage H., Kisters K., Dietl K.H., and Rahn K.H. Sympathetic nerve activity in end-stage renal disease. Circulation 106 (2002) 1974-1999
74. Klein I.E., Ligtenberg G., Oey P.L., Koomans H.A., and Blankestijn P.J. Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. J Am Soc Nephrol 12 (2001) 2427-2433
75. Neumann J., Ligtenberg G., Klein I.E., Boer P., Oey P.L., Koomans H.A., and Blankestijn P.J. Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension 49 (2007) 506-510